383 related articles for article (PubMed ID: 9326912)
21. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
[TBL] [Abstract][Full Text] [Related]
22. Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein LE; Madoc-Jones H
Cancer; 1995 May; 75(9):2281-5. PubMed ID: 7712437
[TBL] [Abstract][Full Text] [Related]
23. Second malignant tumors after elective end of therapy for a first cancer in childhood: a multicenter study in Italy.
Rosso P; Terracini B; Fears TR; Jankovic M; Fossati Bellani F; Arrighini A; Carli M; Cordero di Montezemolo L; Garrè ML; Guazzelli C
Int J Cancer; 1994 Nov; 59(4):451-6. PubMed ID: 7960210
[TBL] [Abstract][Full Text] [Related]
24. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
Abdel-Rahman O
Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
[TBL] [Abstract][Full Text] [Related]
25. Increased risk of second primary cancers after a diagnosis of melanoma.
Bradford PT; Freedman DM; Goldstein AM; Tucker MA
Arch Dermatol; 2010 Mar; 146(3):265-72. PubMed ID: 20231496
[TBL] [Abstract][Full Text] [Related]
26. Secondary malignant neoplasms in testicular cancer survivors.
Curreri SA; Fung C; Beard CJ
Urol Oncol; 2015 Sep; 33(9):392-8. PubMed ID: 26072728
[TBL] [Abstract][Full Text] [Related]
27. Treatment-associated leukemia following testicular cancer.
Travis LB; Andersson M; Gospodarowicz M; van Leeuwen FE; Bergfeldt K; Lynch CF; Curtis RE; Kohler BA; Wiklund T; Storm H; Holowaty E; Hall P; Pukkala E; Sleijfer DT; Clarke EA; Boice JD; Stovall M; Gilbert E
J Natl Cancer Inst; 2000 Jul; 92(14):1165-71. PubMed ID: 10904090
[TBL] [Abstract][Full Text] [Related]
28. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence.
Metayer C; Lynch CF; Clarke EA; Glimelius B; Storm H; Pukkala E; Joensuu T; van Leeuwen FE; van't Veer MB; Curtis RE; Holowaty EJ; Andersson M; Wiklund T; Gospodarowicz M; Travis LB
J Clin Oncol; 2000 Jun; 18(12):2435-43. PubMed ID: 10856104
[TBL] [Abstract][Full Text] [Related]
29. The risk of developing second cancers among survivors of childhood soft tissue sarcoma.
Cohen RJ; Curtis RE; Inskip PD; Fraumeni JF
Cancer; 2005 Jun; 103(11):2391-6. PubMed ID: 15852362
[TBL] [Abstract][Full Text] [Related]
30. Risk of leukemia following treatment for non-Hodgkin's lymphoma.
Travis LB; Curtis RE; Stovall M; Holowaty EJ; van Leeuwen FE; Glimelius B; Lynch CF; Hagenbeek A; Li CY; Banks PM
J Natl Cancer Inst; 1994 Oct; 86(19):1450-7. PubMed ID: 8089863
[TBL] [Abstract][Full Text] [Related]
31. Occurrence of primary cancers in association with multiple myeloma and Kaposi's sarcoma in the United States, 1973-1995.
Cannon MJ; Flanders WD; Pellett PE
Int J Cancer; 2000 Feb; 85(4):453-6. PubMed ID: 10699913
[TBL] [Abstract][Full Text] [Related]
32. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
Shah BK; Khanal A
Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
[TBL] [Abstract][Full Text] [Related]
33. Second malignancies in long-term testicular cancer survivors.
Ondrus D; Ondrusova M; Friedova L
Int Urol Nephrol; 2014 Apr; 46(4):749-56. PubMed ID: 24096370
[TBL] [Abstract][Full Text] [Related]
34. Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study.
Pawlish KS; Schottenfeld D; Severson R; Montie JE
Prostate; 1997 Oct; 33(2):75-86. PubMed ID: 9316648
[TBL] [Abstract][Full Text] [Related]
35. Second cancer risk following testicular cancer: a follow-up study of 1,909 patients.
van Leeuwen FE; Stiggelbout AM; van den Belt-Dusebout AW; Noyon R; Eliel MR; van Kerkhoff EH; Delemarre JF; Somers R
J Clin Oncol; 1993 Mar; 11(3):415-24. PubMed ID: 8445415
[TBL] [Abstract][Full Text] [Related]
36. Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma.
Lewinshtein D; Gulati R; Nelson PS; Porter CR
BJU Int; 2012 Mar; 109(5):706-12. PubMed ID: 21883828
[TBL] [Abstract][Full Text] [Related]
37. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma.
Neugut AI; Ahsan H; Robinson E; Ennis RD
Cancer; 1997 Apr; 79(8):1600-4. PubMed ID: 9118045
[TBL] [Abstract][Full Text] [Related]
38. Second primary cancers following non-Hodgkin's lymphoma in Japan: increased risk of hepatocellular carcinoma.
Tanaka H; Tsukuma H; Teshima H; Ajiki W; Koyama Y; Kinoshita N; Masaoka T; Oshima A
Jpn J Cancer Res; 1997 Jun; 88(6):537-42. PubMed ID: 9263530
[TBL] [Abstract][Full Text] [Related]
39. Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.
Berrington de Gonzalez A; Wong J; Kleinerman R; Kim C; Morton L; Bekelman JE
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):295-302. PubMed ID: 25636756
[TBL] [Abstract][Full Text] [Related]
40. Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era.
Morton LM; Dores GM; Schonfeld SJ; Linet MS; Sigel BS; Lam CJK; Tucker MA; Curtis RE
JAMA Oncol; 2019 Mar; 5(3):318-325. PubMed ID: 30570657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
